A carboxylic acid substituted amphiphilic diblock copolymer scaffold with a hydrophilic PEG‐chain and hydrophobic biodegradable poly(caprolactone) (PCL), which forms a cisplatin anticancer drug is reported herein. Cisplatin [ cis ‐dichloro‐diammine platinum(II), CDDP] was anchored on the polymer backbone through Pt–OOC–PCL chemical linkage that enabled self‐assembly of the prodrug to produce 110 ± 10 nm nanoparticles in water. These drug loaded nanoparticles were characterized by dynamic light scattering, electron microscopy, and X‐ray diffraction. The polymer‐drug conjugate burst instantaneously in saline and PBS to release 35 % of the cisplatin drug for immediate administration. The remaining drug that retained in the polymer scaffold underwent slow and controlled release to deliver the drug over a period of 6–7 d. In the presence of esterase enzyme; the biodegradable PCL aliphatic ester backbone broke completely to release 100 % loaded drugs within a few hours. This biodegradable diblock copolymer design strategy opens up new platform for cisplatin‐polymer drug delivery approach.
No takes yet. Share an insight, caveat, or question.
Surnar et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: